Publicaciones en colaboración con investigadores/as de Universitat de Barcelona (15)

2023

  1. Adequacy of the 10 mg/kg Daily Dose of Antituberculosis Drug Isoniazid in Infants under 6 Months of Age

    Antibiotics, Vol. 12, Núm. 2

2022

  1. Children living with HIV in Europe: do migrants have worse treatment outcomes?

    HIV Medicine, Vol. 23, Núm. 2, pp. 186-196

  2. Integrase inhibitors in children and adolescents: Clinical use and resistance

    Journal of Antimicrobial Chemotherapy, Vol. 77, Núm. 10, pp. 2784-2792

  3. Risk scores for Kawasaki disease, a management tool developed by the KAWA-RACE cohort

    Clinical Rheumatology, Vol. 41, Núm. 12, pp. 3759-3768

2020

  1. Growth Patterns in Children with Congenital Cytomegalovirus Infection

    Pediatric Infectious Disease Journal, pp. 1230-1235

  2. Longitudinal evolution of vertically HIV/HCV–co-infected vs HCV–mono-infected children

    Journal of Viral Hepatitis, Vol. 27, Núm. 1, pp. 61-67

2019

  1. Sociodemographic changes and trends in the rates of new perinatal HIV diagnoses and transmission in Spain from 1997 to 2015

    PLoS ONE, Vol. 14, Núm. 10

2018

  1. The Spanish Society of Paediatric Infectious Diseases guidelines on the prevention, diagnosis and treatment of neonatal herpes simplex infections

    Anales de Pediatria, Vol. 89, Núm. 1, pp. 64.e1-64.e10

2017

  1. New diagnoses of human immunodeficiency virus infection in the Spanish pediatric HIV Cohort (CoRISpe) from 2004 to 2013

    Medicine (United States), Vol. 96, Núm. 39

2016

  1. Prevalence and effect of pre-treatment drug resistance on the virological response to antiretroviral treatment initiated in HIV-infected children - a EuroCoord-CHAIN-EPPICC joint project

    BMC Infectious Diseases, Vol. 16, Núm. 1

2014

  1. Post-licensing safety of fosamprenavir in HIV-infected children in Europe

    Pharmacoepidemiology and Drug Safety, Vol. 23, Núm. 3, pp. 321-325

2013

  1. The incidence of AIDS-defining illnesses at a current CD4 count ≥200 cells/μL in the post-combination antiretroviral therapy era

    Clinical Infectious Diseases, Vol. 57, Núm. 7, pp. 1038-1047

  2. Use of combination neonatal prophylaxis for the prevention of mother-to-child transmission of HIV infection in European high-risk infants

    AIDS, Vol. 27, Núm. 6, pp. 991-1000

2010

  1. Is it safe to discontinue primary pneumocystis jiroveci pneumonia prophylaxis in patients with virologically suppressed HIV infection and a CD4 Cell Count <200 Cells/μL?

    Clinical Infectious Diseases, Vol. 51, Núm. 5, pp. 611-619

1998

  1. Proxy-perceived prior health status and hospital outcome among the critically ill: Is there any relationship?

    Intensive Care Medicine, Vol. 24, Núm. 7, pp. 691-698